CRT 2025

Late-Breaking Clinical Trials Structural

Outcomes in the ALIGN-AR Continued Access Study for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Speaker(s)

• 

  Raj Makkar, MD, FSCAI, FACC

  Vice President of Cardiovascular Innovation and Intervention
  Cedars-Sinai Medical Center
  Los Angeles, California, United States

  Disclosure information not submitted.